Download
1 / 1
10 likes | 20 Views
A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders<br><br>Roots Analysis has announced the addition of u201cGlobal Psychedelic Therapeutics Market, 2020-2030u201d report to its list of offerings. <br><br>The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:<br>uf0a7tA detailed assessment of the current market landscape of drug developers engaged in the development of psychedelic therapeutics. <br>uf0a7tTabulated profiles of prominent psychedelic therapeutics developers. shortlisted on the basis of the number of pipeline products).<br>uf0a7tDetailed profiles of developers of next generation immune checkpoint modulators (shortlisted on the basis having two or more psychedelics-based therapies in phase II clinical studies and above).<br>uf0a7tAn insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics.<br>uf0a7tA list of key opinion leaders (KOLs) within this domain, and detailed 2u00d72 matrices to assess the relative experience of key individuals who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field. <br>uf0a7tA detailed analysis of nearly 545 grants that have been awarded to research institutes engaged in psychedelic therapeutics projects, in the period between 2015 and 2020 (till May). <br>uf0a7tAn analysis of the partnerships that have been established in the recent past (2017-2020 till May), <br>uf0a7tA detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2017-2020.<br>uf0a7tA detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)<br>uf0a7tTarget Disease Indication <br>uf0a7tAnxiety and Depression<br>uf0a7tTrauma <br>uf0a7tPain Disorder<br>uf0a7tSleep related Disorder<br>uf0a7tOrigin of Psychedelic Substance<br>uf0a7tNatural<br>uf0a7tSynthetic<br>uf0a7tType of Psychedelic Substance<br>uf0a7tGamma-hydroxybutyrate<br>uf0a7tKetamine<br>uf0a7tMDMA<br>uf0a7tPsilocybin<br>uf0a7tRoute of Administration<br>uf0a7tOral<br>uf0a7tIntranasal<br>uf0a7tSublingual<br>uf0a7tKey Geographies <br>uf0a7tNorth America<br>uf0a7tEurope<br>uf0a7tAsia-Pacific<br>Transcripts of interviews held with the following senior level representatives of stakeholder companies<br>uf0a7tAndrew Chadeayne (Founder & Chief Executive Officer, CaaMTech)<br>uf0a7tJanakan Krishnarajah (Chief Operating Officer and Chief Medical Officer, iX Biopharma)<br>uf0a7tAlexander Speiser (Chief Operating Officer, Orthogonal Thinker)<br>uf0a7tTracy Cheung, (Chief Communications Officer, COMPASS Pathways)<br>Key companies covered in the report <br>uf0a7tCelon Pharma <br>uf0a7tiX Biopharma <br>uf0a7tMAPS Public Benefit <br>uf0a7tMindMed <br>uf0a7tJanssen Pharmaceuticals <br>uf0a7tJazz Pharmaceutical <br><br>For additional details, please visit <br>https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html or email sales@rootsanalysis.com<br><br>You may also be interested in the following titles: <br>1.tEndocannabinoid System Targeted Therapeutics Market, 2020-2030<br>2.tDepressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant Depression and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019<br>3.tAlzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights<br>4.tNeoantigen Targeted Therapies Market, 2019-2030<br>5.tBlood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics<br><br>About Roots Analysis<br>Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If youu2019d like help with your growing business needs, get in touch at info@rootsanalysis.com<br><br>Contact Information<br>Roots Analysis Private Limited<br>Gaurav Chaudhary<br> 1 (415) 800 3415<br>ben.johnson@rootsanalysis.com<br>Facebook - https://www.facebook.com/RootsAnalysis<br>LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
E N D
